365 related articles for article (PubMed ID: 26713748)
21. Distribution of technetium-99m PEG-liposomes during oligofructose-induced laminitis development in horses.
Underwood C; Pollitt CC; Metselaar JM; Laverman P; van Bloois L; van den Hoven JM; Storm G; van Eps AW
Vet J; 2015 Nov; 206(2):218-25. PubMed ID: 26403954
[TBL] [Abstract][Full Text] [Related]
22. Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis.
Bailey SR; Adair HS; Reinemeyer CR; Morgan SJ; Brooks AC; Longhofer SL; Elliott J
Vet Immunol Immunopathol; 2009 Jun; 129(3-4):167-73. PubMed ID: 19091426
[TBL] [Abstract][Full Text] [Related]
23. Plasma fructosamine concentrations in horses with pituitary pars intermedia dysfunction with and without laminitis.
Knowles EJ; Menzies-Gow NJ; Mair TS
Equine Vet J; 2014 Mar; 46(2):249-51. PubMed ID: 23663105
[TBL] [Abstract][Full Text] [Related]
24. Factors associated with survival, laminitis and insulin dysregulation in horses diagnosed with equine pituitary pars intermedia dysfunction.
Horn R; Bamford NJ; Afonso T; Sutherland M; Buckerfield J; Tan RHH; Secombe CJ; Stewart AJ; Bertin FR
Equine Vet J; 2019 Jul; 51(4):440-445. PubMed ID: 30417404
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for equine laminitis: a case-control study conducted in veterinary-registered horses and ponies in Great Britain between 2009 and 2011.
Wylie CE; Collins SN; Verheyen KL; Newton JR
Vet J; 2013 Oct; 198(1):57-69. PubMed ID: 24070987
[TBL] [Abstract][Full Text] [Related]
26. The pharmacologic basis for the treatment of endocrinopathic laminitis.
Durham A
Vet Clin North Am Equine Pract; 2010 Aug; 26(2):303-14. PubMed ID: 20699177
[TBL] [Abstract][Full Text] [Related]
27. Hindlimb laminar inflammatory response is similar to that present in forelimbs after carbohydrate overload in horses.
Leise BS; Faleiros RR; Watts M; Johnson PJ; Black SJ; Belknap JK
Equine Vet J; 2012 Nov; 44(6):633-9. PubMed ID: 22212091
[TBL] [Abstract][Full Text] [Related]
28. Equine laminitis: comparative histopathology 48 hours after experimental induction with insulin or alimentary oligofructose in standardbred horses.
de Laat MA; van Eps AW; McGowan CM; Sillence MN; Pollitt CC
J Comp Pathol; 2011 Nov; 145(4):399-409. PubMed ID: 21429503
[TBL] [Abstract][Full Text] [Related]
29. Assessment of horse owners' ability to recognise equine laminitis: A cross-sectional study of 93 veterinary diagnosed cases in Great Britain.
Pollard D; Wylie CE; Verheyen KLP; Newton JR
Equine Vet J; 2017 Nov; 49(6):759-766. PubMed ID: 28543943
[TBL] [Abstract][Full Text] [Related]
30. Thromboxane and isoprostanes as inflammatory and vasoactive mediators in black walnut heartwood extract induced equine laminitis.
Noschka E; Moore JN; Peroni JF; Lewis SJ; Morrow JD; Robertson TP
Vet Immunol Immunopathol; 2009 Jun; 129(3-4):200-10. PubMed ID: 19111354
[TBL] [Abstract][Full Text] [Related]
31. Incidence and risk factors for recurrence of endocrinopathic laminitis in horses.
de Laat MA; Reiche DB; Sillence MN; McGree JM
J Vet Intern Med; 2019 May; 33(3):1473-1482. PubMed ID: 30972832
[TBL] [Abstract][Full Text] [Related]
32. Identification of modifiable factors associated with owner-reported equine laminitis in Britain using a web-based cohort study approach.
Pollard D; Wylie CE; Verheyen KLP; Newton JR
BMC Vet Res; 2019 Feb; 15(1):59. PubMed ID: 30755193
[TBL] [Abstract][Full Text] [Related]
33. A multicenter, matched case-control study of risk factors for equine laminitis.
Alford P; Geller S; Richrdson B; Slater M; Honnas C; Foreman J; Robinson J; Messer M; Roberts M; Goble D; Hood D; Chaffin M
Prev Vet Med; 2001 May; 49(3-4):209-22. PubMed ID: 11311954
[TBL] [Abstract][Full Text] [Related]
34. A potential role for lamellar insulin-like growth factor-1 receptor in the pathogenesis of hyperinsulinaemic laminitis.
de Laat MA; Pollitt CC; Kyaw-Tanner MT; McGowan CM; Sillence MN
Vet J; 2013 Aug; 197(2):302-6. PubMed ID: 23394844
[TBL] [Abstract][Full Text] [Related]
35. Equine laminitis: what is all the hype about hyperinsulinaemic laminitis?
Wylie CE
Vet J; 2013 May; 196(2):139-40. PubMed ID: 23168265
[No Abstract] [Full Text] [Related]
36. Mitogen-activated kinase pathway activation in epidermal lamellae in the acute stages of carbohydrate overload laminitis models and the effect of regional deep hypothermia on signalling pathways.
Gardner AK; Kelly CS; van Eps AW; Burns TA; Watts MR; Belknap JK
Equine Vet J; 2016 Sep; 48(5):633-40. PubMed ID: 26222495
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the possible role of prostaglandin F(2 alpha) in laminitis induced in horses by nasogastric administration of black walnut heartwood extract.
Noschka E; Moore JN; Peroni JF; Lewis TH; Lewis SJ; Robertson TP
Am J Vet Res; 2010 Feb; 71(2):186-93. PubMed ID: 20113226
[TBL] [Abstract][Full Text] [Related]
38. Continuous intravenous infusion of glucose induces endogenous hyperinsulinaemia and lamellar histopathology in Standardbred horses.
de Laat MA; Sillence MN; McGowan CM; Pollitt CC
Vet J; 2012 Mar; 191(3):317-22. PubMed ID: 21873088
[TBL] [Abstract][Full Text] [Related]
39. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
[TBL] [Abstract][Full Text] [Related]
40. Continuous digital hypothermia prevents lamellar failure in the euglycaemic hyperinsulinaemic clamp model of equine laminitis.
Stokes SM; Belknap JK; Engiles JB; Stefanovski D; Bertin FR; Medina-Torres CE; Horn R; van Eps AW
Equine Vet J; 2019 Sep; 51(5):658-664. PubMed ID: 30636340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
